0001551986-23-000026.txt : 20230421 0001551986-23-000026.hdr.sgml : 20230421 20230421170833 ACCESSION NUMBER: 0001551986-23-000026 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230421 FILED AS OF DATE: 20230421 DATE AS OF CHANGE: 20230421 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sensenig Bethany CENTRAL INDEX KEY: 0001899935 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37797 FILM NUMBER: 23837186 MAIL ADDRESS: STREET 1: C/O 9 METERS BIOPHARMA, INC. STREET 2: 8480 HONEYCUTT ROAD, SUITE 120 CITY: RALEIGH STATE: NC ZIP: 27615 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: 9 METERS BIOPHARMA, INC. CENTRAL INDEX KEY: 0001551986 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 273948465 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4509 CREEDMOOR ROAD STREET 2: SUITE 201 CITY: RALEIGH STATE: NC ZIP: 27612 BUSINESS PHONE: 919-275-1933 MAIL ADDRESS: STREET 1: 4509 CREEDMOOR ROAD STREET 2: SUITE 201 CITY: RALEIGH STATE: NC ZIP: 27612 FORMER COMPANY: FORMER CONFORMED NAME: INNOVATE BIOPHARMACEUTICALS, INC. DATE OF NAME CHANGE: 20180201 FORMER COMPANY: FORMER CONFORMED NAME: Monster Digital, Inc. DATE OF NAME CHANGE: 20150930 FORMER COMPANY: FORMER CONFORMED NAME: Tandon Digital, Inc. DATE OF NAME CHANGE: 20120611 4 1 wf-form4_168211130140021.xml FORM 4 X0407 4 2023-04-21 0 0001551986 9 METERS BIOPHARMA, INC. NMTR 0001899935 Sensenig Bethany C/O 9 METERS BIOPHARMA, INC. 4509 CREEDMOOR RD, STE 600 RALEIGH NC 27612 0 1 0 0 Chief Financial Officer 0 Common stock 2023-04-21 4 S 0 9100 1.21 D 41077 D Reflects shares sold to cover taxes upon the vesting of restricted stock units on April 15, 2023. The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $1.20 to $1.23. The reporting person undertakes to provide to 9 Meters Biopharma, Inc., any security holder of 9 Meters Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 2 to this Form 4. /s/ Lorna A. Knick, as power of attorney 2023-04-21